SUBSCRIBE
SUBSCRIBE
News   Policy

FDA Panel Rejects Protein Sciences Corporation’s Cell Culture Flu Vaccine, Wants More Safety Data

November 20, 2009 | 
1 min read
Bookmark and Share

Reuters -- More safety data would be needed before a new type of influenza vaccine made in insect cells should get approval, federal advisers said on Thursday.
Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Illustration of man walking in the beach between two blue seas, surreal abstract path concept
Rare disease
FDA’s Bespoke Pathway To Focus on Gene Editing and RNA-Based Treatments for Rare Diseases
February 23, 2026
 · 
3 min read
 · 
Nick Paul Taylor
Contemporary art collage. Businessmen, employees walking into open door symbolizing new opportunities. Way to success. Concept of business, promotion, motivation, ambitions and ideas
Government
Kennedy Ally Departs CDC Amid Leadership Shake-Up
February 23, 2026
 · 
1 min read
 · 
Annalee Armstrong
Conceptual origami paper plane pulling business finance growth chart line flying upwards on blue sky background.
Approvals
Vanda Rebounds From Jet Lag Rejection With FDA Nod for Bipolar, Schizophrenia Drug
February 23, 2026
 · 
2 min read
 · 
Tristan Manalac
Collage halftone banner with two hands that put objects on scales. Halftone hands holding circle and square and put them on the scales. Concept of business balance in teamwork. Vector illustration.
Legal
REGENXBIO Secures Legal Win in Gene Therapy Patent Battle Vs. Sarepta
February 23, 2026
 · 
2 min read
 · 
Tristan Manalac